Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HBK Investments is a global alternative investment management firm that operates as a multi-strategy hedge fund. Founded in 1991 and headquartered in Dallas, Texas, the firm manages a diverse portfolio across various asset classes, including equities, fixed income, and derivatives. Within the life sciences and healthcare sectors, HBK is a prominent institutional investor, frequently participating in private equity rounds, crossover financings, and initial public offerings. The firm's healthcare investment strategy focuses on identifying innovative biotechnology and medical technology companies with high growth potential. HBK maintains a significant global presence with additional offices in New York, London, and Hong Kong, and is recognized as one of the largest employee-owned investment firms in the industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HBK Investments.